Topical finasteride therapy in hirsutism

Endocrine Practice

Volumn 7, Issue 1, 2001, Pages 64-65

  Rodriguez Rigau, L J ^a  

^a Texas Institute for Reproductive Medicine and Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIANDROGEN; CYPROTERONE ACETATE; ENZYME INHIBITOR; ESTROGEN; FINASTERIDE; HORMONE RECEPTOR; ISOENZYME; ORAL CONTRACEPTIVE AGENT; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; TESTOSTERONE 5 ALPHA REDUCTASE;

CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EDITORIAL; ENZYME ACTIVITY; FACE DISORDER; FEMALE; HAIR DISEASE; HAIR GROWTH; HIRSUTISM; HORMONE ACTION; HUMAN; LABORATORY TEST; PATHOGENESIS; TERATOGENICITY; TREATMENT CONTRAINDICATION; TREATMENT PLANNING; UNITED STATES; INTRADERMAL DRUG ADMINISTRATION; NOTE;

ADMINISTRATION, CUTANEOUS; ENZYME INHIBITORS; FEMALE; FINASTERIDE; HIRSUTISM; HUMAN; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0034840496     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.7.1.64     Document Type: Editorial

References (8)

1. Clinical assessment of body hair growth in women
2. The prevalence of hirsutism in young women
3. Serum testosterone levels and reference ranges in reproductive-age women
4. Utilization of commercial laboratory results in management of hyperandrogenism in women
5. Treatment of hirsutism: Antiandrogen and 5 alpha-reductase inhibitor therapy
6. Round table discussion: Session 6
7. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double blind, placebo-controlled trial
8. A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea